Marisa Liang, PA
Physician Assistant · Modesto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Sutter Valley Medical Foundation · 2,473 clinicians in this group
Hospitals listed: Memorial Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Marisa Liang’s office at (209) 524-1211 to ask if they take your plan before you enroll.
California Medical Board record
Licence G52295 · Cancelled
Licence status: Cancelled · since 1984 · University of Missouri-Columbia School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Washington PA.PA.61234461Physician Assistant License · since 2021 · expires 2024-09-02ExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Memorial Medical CenterModesto, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.093, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.085, Oct 2024 – Sep 2025
See every measure and the patient survey for Memorial Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.093 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.085 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.3 (0.41 to 2.2) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.75 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 185.77 (144.66 to 226.88) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.2 · 237 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 14.1 · 194 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.9 · 513 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.4 · 640 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 278 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 4,882 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.42) · 10,183 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 10,422 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.4 (1.58 to 5.23) · 2,596 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.92 (0.45 to 3.38) · 845 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.1 (1.78 to 4.42) · 2,439 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.71 (5.69 to 17.72) · 885 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.28 (3.75 to 10.81) · 829 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 563 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.2 (0 to 0.72) · 9,080 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 283 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.389 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.485 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.507 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 255 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 849 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 19.2 · 201 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -8.4 · 584 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 26.6 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 895 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.8 (3.3 to 6.9) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (8.4 to 14.3) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 273 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.7 · 108 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 341 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (10.2 to 16.1) · 2,334 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 717 cases | No different | Jan 2024 – Dec 2024 |
What patients said (655 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$262,988
Medicare paid this office $262,988 for 607 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, denosumab, 1 mg | 91 | $113,800 | None |
| Return visit (30+ min) | 589 | $69,657 | $84 |
| Injection, romosozumab-aqqg, 1 mg | 13 | $62,961 | None |
| Injection of drug or substance under skin or into muscle | 109 | $1,713 | $10 |
| Hemoglobin a1c level | 84 | $904 | $10 |
Who their Medicare patients are
607 Original Medicare patients in 2024. Average age 74 · Under 65 11% · 85 and older 10% · Women 66% · Also on Medicaid 27% · Health risk score 1.65. Above the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 75% · Diabetes 70% · Chronic kidney disease 56% · Coronary heart disease 38% · Depression 23% · Heart failure 21% · Atrial fibrillation 19% · COPD 16% · Cancer 13% · Stroke 9% · Dementia 4%.
The office billed $793,034, Medicare allowed $334,348 and paid $262,988; for 14,838 services of 16 kinds; $189,621 of it was for drugs given in the office and $73,367 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 607 | 14,838 | 74 | 1.65 | $793,034 | $262,988 |
| 2023 | 85 | 114 | 66 | 1.88 | $67,586 | $7,588 |
| 2022 | 150 | 194 | 69 | 1.38 | $102,303 | $14,180 |
| 2021 | 488 | 570 | 71 | 1.82 | $429,461 | $48,600 |
| 2020 | 323 | 427 | 70 | 1.84 | $263,644 | $28,964 |
| 2019 | 667 | 877 | 71 | 1.76 | $547,129 | $64,755 |
| 2018 | 437 | 507 | 68 | 1.65 | $239,120 | $39,650 |
| 2017 | 199 | 228 | 68 | 1.91 | $97,622 | $17,316 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Emergency department visit with high level of medical decision making | 41 | $4,173 | $99 |
| Emergency department visit with moderate level of medical decision making | 34 | $2,452 | $66 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 13 | $72 | $6 |
2022: 4 services
| Emergency department visit with high level of medical decision making | 49 | $6,813 | $129 |
| Emergency department visit with moderate level of medical decision making | 54 | $4,553 | $84 |
| Emergency department visit with low level of medical decision making | 31 | $1,544 | $48 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 25 | $152 | $6 |
2021: 4 services
| Emergency department visit with high level of medical decision making | 164 | $21,399 | $124 |
| Emergency department visit with moderate level of medical decision making | 192 | $15,719 | $79 |
| Emergency department visit with low level of medical decision making | 132 | $6,065 | $45 |
| Critical care, first 30-74 minutes | 24 | $3,845 | $160 |
2020: 5 services
| Emergency department visit with high level of medical decision making | 105 | $11,745 | $112 |
| Emergency department visit with moderate level of medical decision making | 97 | $7,184 | $73 |
| Emergency department visit with low level of medical decision making | 107 | $4,544 | $40 |
| Critical care, first 30-74 minutes | 23 | $3,984 | $159 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 57 | $345 | $6 |
2019: 5 services
| Emergency department visit with high level of medical decision making | 270 | $32,322 | $112 |
| Emergency department visit with moderate level of medical decision making | 220 | $17,811 | $76 |
| Emergency department visit with low level of medical decision making | 179 | $7,444 | $39 |
| Critical care, first 30-74 minutes | 30 | $4,578 | $148 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 81 | $464 | $6 |
2018: 4 services
| Emergency department visit with high level of medical decision making | 138 | $18,009 | $129 |
| Emergency department visit with moderate level of medical decision making | 123 | $11,086 | $85 |
| Emergency department visit with low level of medical decision making | 187 | $8,803 | $45 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 16 | $103 | $6 |
2017: 3 services
| Emergency department visit with high level of medical decision making | 70 | $8,539 | $120 |
| Emergency department visit with moderate level of medical decision making | 50 | $4,041 | $81 |
| Emergency department visit with low level of medical decision making | 76 | $3,477 | $43 |
Medicaid work
$450 in 2024
Medicaid paid $450 for 100 billed services this clinician did in 2024, up to 20 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 100 | $450 |
| 2024 | 100 | 1 | 20 | $450 |
| 2023 | 686 | 9 | 59 | $93,852 |
| 2022 | 1,338 | 13 | 43 | $132,290 |
| 2021 | 1,658 | 5 | 79 | $110,804 |
| 2020 | 1,224 | 11 | 76 | $62,582 |
| 2019 | 1,710 | 6 | 67 | $97,676 |
| 2018 | 1,080 | 3 | 71 | $69,623 |
See the largest Medicaid services in earlier years
2023
| EMERGENCY DEPT VISIT MOD MDM | 193 | $48,184 |
| EMERGENCY DEPT VISIT LOW MDM | 216 | $39,293 |
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 15 | $4,116 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug | 15 | $1,407 |
| Radiologic examination, chest; 2 views | 14 | $852 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 27 | $0 |
| COMPREHENSIVE METABOLIC PANEL | 48 | $0 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 15 | $0 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 143 | $0 |
2022
| EMERGENCY DEPT VISIT MOD MDM | 256 | $61,230 |
| EMERGENCY DEPT VISIT LOW MDM | 325 | $44,280 |
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 63 | $21,707 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug | 38 | $3,769 |
| Short return visit (20+ min) | 20 | $1,235 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 41 | $68 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 195 | $0 |
| Basic metabolic panel (Calcium, total) This panel must include the following: Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Potassium (84132) Sodium (84295) Urea nitrogen (BUN) (84520) | 12 | $0 |
| COMPREHENSIVE METABOLIC PANEL | 101 | $0 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 32 | $0 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 29 | $0 |
| ASSAY OF LIPASE | 16 | $0 |
2021
| EMERGENCY DEPT VISIT MOD MDM | 533 | $46,343 |
| EMERGENCY DEPT VISIT LOW MDM | 865 | $42,306 |
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 219 | $21,523 |
| EMERGENCY DEPARTMENT VISIT STRAIGHTFORWARD MDM | 13 | $631 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 28 | $0 |
2020
| EMERGENCY DEPT VISIT LOW MDM | 606 | $29,690 |
| EMERGENCY DEPT VISIT MOD MDM | 301 | $22,869 |
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 99 | $9,469 |
| EMERGENCY DEPARTMENT VISIT STRAIGHTFORWARD MDM | 17 | $301 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 72 | $253 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 30 | $0 |
| COMPREHENSIVE METABOLIC PANEL | 15 | $0 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 39 | $0 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 17 | $0 |
| URINE PREGNANCY TEST | 12 | $0 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 16 | $0 |
2019
| EMERGENCY DEPT VISIT MOD MDM | 450 | $36,191 |
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 369 | $33,939 |
| EMERGENCY DEPT VISIT LOW MDM | 610 | $26,705 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 253 | $841 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 13 | $0 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 15 | $0 |
2018
| EMERGENCY DEPT VISIT LOW MDM | 697 | $33,538 |
| EMERGENCY DEPT VISIT MOD MDM | 286 | $25,431 |
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 97 | $10,653 |
Drugs they prescribed that Part D paid
$1,155,290
Pharmacies billed $1,155,290 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,156 generic and 1,216 brand-name prescriptions · $1,155,290 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 137 | $245,274 | $1,790 |
| Mounjaro | 179 | $237,799 | $1,328 |
| Jardiance | 170 | $190,394 | $1,120 |
| Farxiga | 65 | $73,776 | $1,135 |
| Repatha Sureclick | 34 | $36,788 | $1,082 |
See all 48 drugs
| Ozempic | 137 | $245,274 | $1,790 |
| Mounjaro | 179 | $237,799 | $1,328 |
| Jardiance | 170 | $190,394 | $1,120 |
| Farxiga | 65 | $73,776 | $1,135 |
| Repatha Sureclick | 34 | $36,788 | $1,082 |
| Trulicity | 24 | $35,785 | $1,491 |
| Rybelsus | 26 | $31,514 | $1,212 |
| Januvia | 22 | $21,551 | $980 |
| Toujeo Solostar | 24 | $19,636 | $818 |
| Humulin R U-500 Kwikpen | 16 | $16,114 | $1,007 |
| Tradjenta | 16 | $15,827 | $989 |
| Vascepa | 23 | $15,030 | $653 |
| Kerendia | 15 | $14,530 | $969 |
| Bydureon Bcise | 17 | $13,520 | $795 |
| Tresiba Flextouch U-100 | 22 | $13,243 | $602 |
| Praluent | 22 | $11,704 | $532 |
| Fiasp Flextouch | 13 | $11,665 | $897 |
| Humalog Kwikpen U-100 | 37 | $11,182 | $302 |
| Basaglar Kwikpen U-100 | 21 | $10,851 | $517 |
| Lantus Solostar | 68 | $10,654 | $157 |
| Ezetimibe | 91 | $4,367 | $48 |
| Nano 2nd Gen Pen Needle | 31 | $3,881 | $125 |
| Humalog | 13 | $3,835 | $295 |
| Insulin Lispro Kwikpen U-100 | 18 | $3,654 | $203 |
| Novolog Flexpen | 17 | $3,629 | $213 |
| Synthroid | 34 | $3,509 | $103 |
| Levothyroxine | 167 | $2,290 | $14 |
| Acarbose | 30 | $1,778 | $59 |
| Lantus | 13 | $1,730 | $133 |
| Pioglitazone | 120 | $1,600 | $13 |
| Metformin Hcl Er | 69 | $1,164 | $17 |
| Atorvastatin | 138 | $1,013 | $7 |
| Glipizide Er | 91 | $983 | $11 |
| Metformin | 78 | $711 | $9 |
| Rosuvastatin | 40 | $622 | $16 |
| Gabapentin | 22 | $610 | $28 |
| Losartan | 50 | $396 | $8 |
| Simvastatin | 18 | $285 | $16 |
| Amlodipine Besylate | 52 | $248 | $5 |
| Methimazole | 18 | $221 | $12 |
| Carvedilol | 16 | $204 | $13 |
| Alendronate | 18 | $125 | $7 |
| Lisinopril | 16 | $124 | $8 |
| Metoprolol | 12 | $103 | $9 |
| Glimepiride | 17 | $98 | $6 |
| Repaglinide | 11 | $96 | $9 |
| Hydrochlorothiazide | 16 | $29 | $2 |
| Dexamethasone | 11 | $13 | $1 |
Year by year
| 2024 | 2,449 | 667 | None | 50% | $1,155,290 |
| 2023 | 165 | 132 | 19% (32) | None | $1,144 |
| 2022 | 258 | 172 | 20% (51) | None | $3,699 |
| 2021 | 274 | 183 | 29% (79) | None | $3,700 |
| 2020 | 200 | 123 | 19% (37) | None | $6,964 |
| 2019 | 393 | 233 | 24% (93) | 5% | $3,319 |
| 2018 | 300 | 187 | 28% (85) | None | $3,268 |
| 2017 | 160 | 105 | 24% (38) | None | $2,703 |
| 2016 | 87 | 24 | None | None | $2,538 |
| 2015 | 85 | 52 | 19% (16) | None | $1,061 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Cephalexin | 28 | $191 | $7 |
| Hydrocodone-Acetaminophen | 19 | $75 | $4 |
| Ciprofloxacin | 12 | $71 | $6 |
2022: 5 drugs
| Cephalexin | 43 | $301 | $7 |
| Amoxicillin-Clavulanate Potass | 12 | $151 | $13 |
| Hydrocodone-Acetaminophen | 27 | $101 | $4 |
| Ondansetron Odt | 11 | $84 | $8 |
| Doxycycline Hyclate | 11 | $82 | $7 |
2021: 6 drugs
| Hydrocodone-Acetaminophen | 58 | $229 | $4 |
| Cephalexin | 32 | $177 | $6 |
| Cyclobenzaprine | 11 | $45 | $4 |
| Oxycodone | 17 | $43 | $3 |
| Sulfamethoxazole-Trimethoprim | 12 | $35 | $3 |
| Prednisone | 11 | $23 | $2 |
2020: 4 drugs
| Cephalexin | 31 | $169 | $5 |
| Hydrocodone-Acetaminophen | 27 | $99 | $4 |
| Sulfamethoxazole-Trimethoprim | 11 | $35 | $3 |
| Prednisone | 12 | $26 | $2 |
2019: 9 drugs
| Hydrocodone-Acetaminophen | 57 | $247 | $4 |
| Methylprednisolone | 12 | $182 | $15 |
| Cephalexin | 24 | $178 | $7 |
| Ondansetron Odt | 24 | $146 | $6 |
| Sulfamethoxazole-Trimethoprim | 27 | $118 | $4 |
| Cyclobenzaprine | 25 | $74 | $3 |
| Ibuprofen | 21 | $65 | $3 |
| Oxycodone | 20 | $55 | $3 |
| Prednisone | 17 | $50 | $3 |
2018: 5 drugs
| Hydrocodone-Acetaminophen | 64 | $295 | $5 |
| Cephalexin | 26 | $191 | $7 |
| Methylprednisolone | 11 | $155 | $14 |
| Cyclobenzaprine | 13 | $57 | $4 |
| Ibuprofen | 15 | $50 | $3 |
2017: 1 drug
| Hydrocodone-Acetaminophen | 25 | $102 | $4 |
2015: 1 drug
| Ibuprofen | 11 | $45 | $4 |
Money from drug and device companies
$969 in 2025
| 2025 | 10 | 16 | None | $969 |
| 2024 | 7 | 12 | None | $1,150 |
| 2023 | 2 | 2 | None | $187 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ascendis Pharma Endocrinology | Yorvipath | $265 | 3 payments
|
| Amgen | Repatha | $255 | 3 payments
|
| Lilly USA | Zepbound | $107 | 2 payments
|
| Corcept Therapeutics | Korlym | $105 | 1 payment
|
| Beta Bionics | Ilet Bionic Pancreas | $89 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | None | $55 | 1 payment
|
See all 16 published payments
| Amgen | Meals · 2025-11-18 | Repatha | $109 |
| Novartis Pharmaceuticals | Meals · 2025-11-13 | Leqvio | $15 |
| Insulet | Meals · 2025-11-12 | Omnipod | $23 |
| Ascendis Pharma Endocrinology | Meals · 2025-09-23 | Yorvipath | $91 |
| Amgen | Meals · 2025-09-19 | Repatha | $5 |
| Ascendis Pharma Endocrinology | Meals · 2025-08-20 | Yorvipath | $76 |
| Novo Nordisk | Meals · 2025-08-06 | Rybelsus | $15 |
| Madrigal Pharmaceuticals | Meals · 2025-08-06 | Rezdiffra | $24 |
| Lilly USA | Meals · 2025-08-05 | Mounjaro | $51 |
| Amgen | Meals · 2025-06-12 | None | $142 |
| Ascendis Pharma Endocrinology | Meals · 2025-06-09 | Yorvipath | $98 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-15 | None | $55 |
| Lilly USA | Meals · 2025-03-19 | Zepbound | $56 |
| Corcept Therapeutics | Meals · 2025-03-13 | Korlym | $105 |
| Beta Bionics | Meals · 2025-03-11 | Ilet Bionic Pancreas | $89 |
| Novo Nordisk | Meals · 2025-02-26 | Ozempic | $17 |
See earlier years (2024, 2023)
2024: $1,150
| Novo Nordisk | None | $318 | 3 payments
|
| Amgen | Tepezza | $310 | 3 payments
|
| Novartis Pharmaceuticals | Leqvio | $166 | 2 payments
|
| Lilly USA | Mounjaro | $125 | 1 payment
|
| Madrigal Pharmaceuticals | Rezdiffra | $105 | 1 payment
|
| Sanofi-Aventis U.S. | Tzield | $82 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $45 | 1 payment
|
2023: $187
| AstraZeneca Pharmaceuticals LP | Farxiga | $125 | 1 payment
|
| Lilly USA | Mounjaro | $62 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 89.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1154712933
- Licence
- CA 52295, OR PA186341, WA PA61234461California G52295: CancelledWashington PA.PA.61234461: Expired
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 2670 S White Rd, Suite 200, San Jose, CA, 95148
- NPI first listed
- 2015-02-14
- NPI last updated
- 2022-03-24
- NPI record certified
- 2022-03-24
This is when the NPI record was last certified, not a medical board exam.